Abstract:Objective This study aimed to examine the relationship between different left ventricular hypertrophy (LVH) classification criteria according to the American Society of Echocardiography (ASE), and anatomical measurement of LV wall thickness (LVWT) and histological evidence of myocyte hypertrophy. Methods Data from 146 consecutive patients (47 years; 75% were male) who have undergone heart transplantation were analysed. Fixed ventricles were dissected and measured in weight after both atria, great vessels, and epicardial fat were removed. The fixed biventricular weight was calculated as 87% of total weight (the effect of fixed formalin reduced the total weight by 3%). Anatomical LVWT was measured with a ruler at LV free wall where maximal thickness is located. A comprehensive echocardiogram was performed in all patients before heart transplantation. LVM and relative wall thickness (RWT) (2 PWT/LVEDD) were measured by M-mode echocardiography in parasternal long-axis view. Patients were considered to have LVH when the LVM index exceeds 95 g/m2 in women and exceeds 115 g/m2 in men. Patients were considered to have concentric LVH when RWT > 0.42. LVWT was measured using 2D echocardiography perpendicular to the LV long axis. Results Of 146 explanted hearts, dilated cardiomyopathy (CM), cardiac amyloid, and hypertrophic CM were diagnosed in 53 (47%), 1 (1%), and 8 (5%) patients, respectively. Anatomic ventricular mass correlated with echocardiographic LVM (r=0.5, p < 0.01). Anatomic LVWT modestly correlated with echocardiographic LVWT (r=0.2, p=0.01). Of 146 patients, echocardiographic normal LV geometry, concentric LV remodelling, concentric LVH, and eccentric LVH were present in 22 (15%), 6 (4%), 14 (10%), and 104 (71%), respectively. Increased LVWT (≥ 13 mm) assessed by 2-D echocardiography was present in normal LV geometry (5%), concentric LV remodelling (5%), concentric LVH (57%), and eccentric LVH (33%) (p <0.001) in those classified by ASE guidelines. Anatomic LVWT (≥ 13 mm) was present in normal LV geometry (14%), concentric LV remodelling 5%), concentric LVH (14%), and eccentric LVH (80%) (p <0.001) in those classified by ASE guidelines. Histological myocyte hypertrophy was present in normal LV geometry (12%), concentric LV remodelling (2%), concentric LVH (11%), and eccentric LVH (70%) (p <0.001) in those classified by ASE guidelines. Conclusions 2D-derived echocardiographic increased LVWT in patients with LVH defined by increased LVM index was present in approximately 30-50%. Furthermore, anatomical increased LVWT in those with LVH classified by ASE guidelines was present in a varying range of 10-70%. Patients with concentric LVH had a low prevalence of histological myocyte hypertrophy (approximately 10%). Inconsistencies in classification methods reveal the need for more robust LVH terminologies and definition that is consistent across cardiac imaging and anatomico-pathological examination, particularly in patients with CM.

Subclassification of Left Ventricular Hypertrophy Based on Dilation Stratifies Coronary Artery Disease Patients with Distinct Risk

[Clinical Study of Idiopathic Dilated Cardiomyopathy Complicated by Left Ventricular Aneurysm].

Left ventricular hypertrophy, wall thickness, and histological myocyte alteration in end-stage heart failure: a call for a standard definition

Relationship between left atrial/left ventricular diameter ratio and outcomes in patients with hypertrophic cardiomyopathy

Abstract 13937: The Association Between Left Ventricular End-Diastolic Diameter and Long-Term Mortality in Patients With Coronary Artery Disease

Left ventricular geometry characteristics and clinical outcomes in hemodialysis patients with heart failure with preserved ejection fraction

Quantitative Differentiation of Left Atrial Performance in Hypertrophic Cardiomyopathy

Clinical and prognostic implications of left ventricular dilatation in heart failure

Differences in Clinical Features of Hypertrophic Cardiomyopathy with or Without Left Ventricular Enlargement

Left Atrial Reservoir Strain-Based Left Ventricular Diastolic Function Grading and Incident Heart Failure in Hypertrophic Cardiomyopathy

[Left Atrial Size Predicts Adverse Cardiac Events in Patients with Non-Obstruction Hypertrophic Cardiomyopathy].

TCT-387 Short- and Long-term Outcomes of Coronary Revascularization in Patients with Severe Left Ventricular Dilatation

The Prognostic Value of Left Atrial Strain and Strain Rate in Predicting Heart Failure Outcomes in Patients with Hypertrophic Cardiomyopathy and a Left Ventricular Ejection Fraction of 50% or higher.

Association Between Basal Septal Hypertrophy and Left Ventricular Geometry in a Community Population

Effect of Obesity on Left Ventricular Remodeling and Clinical Outcome in Chinese Patients With Hypertrophic Cardiomyopathy: Assessed by Cardiac MRI

Mechanistic and physiological consequences of HPr(ser) phosphorylation on the activities of the phosphoenolpyruvate:sugar phosphotransferase system in gram‐positive bacteria: studies with site‐specific mutants of HPr.

Comparing left atrial indices by CMR in association with left ventricular diastolic dysfunction and adverse clinical outcomes

The Impact of Hypertension on Left Ventricular Function and Remodeling in Non‐Ischemic Dilated Cardiomyopathy Patients: A 3.0 T MRI Study

The Evaluation of Right Ventricular Function of Hypertrophic Cardiomyopathy Using Two Dimensional Strain Imaging

Left ventricular apical aneurysms and outcomes in hypertrophic cardiomyopathy

Identifying left ventricular dysfunction using prospective electrocardiogram-triggered coronary computed tomography angiography